A study about the impact of intensive instruction on the use of Aricept and the reasons for discontinuation in patients with Alzheimer's Disease
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2019
Price : $35 *
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 07 Jun 2018 Status changed from recruiting to completed.
- 20 Jul 2016 Planned End Date changed from 31 Mar 2016 to 30 Sep 2017.
- 24 Dec 2014 Planned End Date changed from 30 Sep 2015 to 31 Mar 2016 as reported by University Hospital Medical Information Network - Japan.